Multiple Sclerosis

Health Condition

Multiple Sclerosis

  • Biotin

    In a preliminary study, supplementation with biotin was associated with an improvement in neurological function in patients with chronic progressive multiple sclerosis.

    Dose:

    Refer to label instructions
    Biotin
    ×
    In a preliminary study, supplementation with large amounts of biotin (100 to 300 mg per day) for an average of 9 months was associated with an improvement in neurological function in a majority of patients with chronic progressive multiple sclerosis.3 The beneficial effect of biotin (300 mg per day for 12 months) was confirmed in a double-blind study of patients with chronic progressive multiple sclerosis, although only 13% of the patients in that study improved.4 Because multiple sclerosis can be a serious illness, and because the amount of biotin used in this study was very large, this treatment should be monitored by a doctor.
  • Fish Oil

    Several studies have shown fish oil to help reduce urinary incontinence, improve eyesight, and reduce relapse rate in people with relapsing-remitting MS.

    Dose:

    6 to 20 grams daily
    Fish Oil
    ×

    In one small trial, people with MS were given approximately 20 grams of fish oil in capsules per day.5 After one to four months, 42% of these people received slight but significant benefits, including reduced urinary incontinence and improved eyesight. However, a longer double-blind trial involving over 300 people with MS found that half this amount of fish oil given per day did not help.[REF] In another trial, combining fish oil supplementation (6 grams per day) with a low-fat diet (15% of total calories) appeared to reduce the relapse rate in people with the relapsing-remitting form of MS.6 However, a double-blind study found that supplementing with the omega-3 fatty acids in fish oil (1,350 mg of EPA and 850 mg of DHA per day) for two years had no effect on disease activity or relapse rate in people with relapsing-remitting MS.7

    In a small preliminary trial, people with MS were given 20 grams of cod liver oil, as well as approximately 680 mg of magnesium and 1,100 mg of calcium per day in the form of dolomite tablets.8 After one year, the average number of MS attacks decreased significantly for each person. Unlike fish oil capsules, the cod liver oil in this trial contained not only eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), but 5,000 IU of vitamin D. Therefore, it is not known whether the vitamin D or fatty acids were responsible for the cod liver oil’s effects. (One preliminary study found that giving vitamin D-like drugs to animals with MS was helpful.)9 It is also possible that the magnesium and/or calcium given to these people reduced MS attacks. Magnesium10 and calcium11 levels have been reported to be lower in the nerve tissue of people with MS compared with healthy people.

  • Padma Basic

    An herbal product called Padma Basic was given to 100 people with MS in one study, and 44% experienced increased muscle strength and general overall improvement.

    Dose:

    2 herbal tablets or capsules three times per day
    Padma Basic
    ×
     

    A commercial herbal product called Padma Basic was given to 100 people with MS.12 After taking two pills three times per day, 44% of these people experienced increased muscle strength and general overall improvement. The composition of Padma Basic is based on a traditional Tibetan herbal formula.

  • Calcium

    Calcium levels have been reported to be low in people with MS. In one study, people given a combination of cod liver oil, magnesium, and calcium had a significantly reduced number of MS attacks.

    Dose:

    Refer to label instructions
    Calcium
    ×

    Caution: Calcium supplements should be avoided by prostate cancer patients.

    In a small preliminary trial, people with MS were given 20 grams of cod liver oil, as well as approximately 680 mg of magnesium and 1,100 mg of calcium per day in the form of dolomite tablets.13 After one year, the average number of MS attacks decreased significantly for each person. Unlike fish oil capsules, the cod liver oil in this trial contained not only eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), but 5,000 IU of vitamin D. Therefore, it is not known whether the vitamin D or fatty acids were responsible for the cod liver oil’s effects. (One preliminary study found that giving vitamin D-like drugs to animals with MS was helpful.)14 It is also possible that the magnesium and/or calcium given to these people reduced MS attacks. Magnesium15 and calcium16 levels have been reported to be lower in the nerve tissue of people with MS compared with healthy people.

  • Conjugated Linoleic Acid

    Omega-6 fatty acids found in sunflower seed oil (a source of linoleic acid) may be beneficial. Studies have reported that linoleic acid reduced relapse severity and length and decreased disability due to MS.

    Dose:

    Refer to label instructions
    Conjugated Linoleic Acid
    ×
    Omega-6 fatty acids found in sunflower seed oil (a source of linoleic acid) may be beneficial. Studies have reported that linoleic acid reduced relapse severity and length and decreased disability due to MS.17
  • Evening Primrose Oil

    The omega-6 fatty acids found in such oils as evening primrose oil (EPO) may be beneficial. When people with MS were given EPO, their hand grip improved in one study.

    Dose:

    Refer to label instructions
    Evening Primrose Oil
    ×
     

    The omega-6 fatty acids, found in such oils as evening primrose oil (EPO) and sunflower seed oil, also may be beneficial. When people with MS were given 4 grams of EPO for three weeks, their hand grip improved.18 In a review of three double-blind trials, two of the trials reported that linoleic acid reduced the severity and length of relapses.19 When the data were re-examined, it was found that taking linoleic acid decreased disability due to MS in all three trials. According to these researchers, taking linoleic acid while following a diet low in animal fat and high in polyunsaturated fat may be even more beneficial. Amounts used in these trials were approximately 17 to 23 grams of linoleic acid per day, provided by 26 to 35 grams of sunflower seed oil.

  • Ginkgo

    Inflammation of nerve tissue is partly responsible for the breakdown of myelin in people with MS. In one study, people with MS showed improvement after being given injections of a constituent of ginkgo.

    Dose:

    Refer to label instructions
    Ginkgo
    ×
     

    Inflammation of nerve tissue is partly responsible for the breakdown of myelin in people with MS. When intravenous injections of a constituent of Ginkgo biloba, known as ginkgolide B, were given to people with MS for five days, 80% of them reportedly improved.20 This specialized treatment is experimental, and it is not known whether oral use of ginkgo extracts would have a similar effect.

  • Inosine

    Inosine is a precursor to uric acid, which is believed to block the effect of a compound that may play a role in MS development. Patients given inosine in order to raise uric acid levels experienced improved function in one study.

    Dose:

    Refer to label instructions
    Inosine
    ×
     

    Inosine is a precursor to uric acid, a compound that occurs naturally in the body. Uric acid is believed to block the effect of a toxic free-radical compound (peroxynitrite) that may play a role in the development of multiple sclerosis.21 In an attempt to raise uric acid levels, ten patients with MS were treated with inosine in amounts up to 3 grams per day for 46 weeks. Three of the ten treated patients showed some evidence of improved function and the others remained stable.21 Controlled studies are needed to confirm these preliminary results.

  • Magnesium

    Magnesium levels have been reported to be low in people with MS. In one trial, a combination of magnesium, cod liver oil, and calcium helped reduce the number of MS attacks.

    Dose:

    Refer to label instructions
    Magnesium
    ×
     

    In a small preliminary trial, people with MS were given 20 grams of cod liver oil, as well as approximately 680 mg of magnesium and 1,100 mg of calcium per day in the form of dolomite tablets.22 After one year, the average number of MS attacks decreased significantly for each person. Unlike fish oil capsules, the cod liver oil in this trial contained not only eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), but 5,000 IU of vitamin D. Therefore, it is not known whether the vitamin D or fatty acids were responsible for the cod liver oil’s effects. (One preliminary study found that giving vitamin D-like drugs to animals with MS was helpful.)23 It is also possible that the magnesium and/or calcium given to these people reduced MS attacks. Magnesium24 and calcium25 levels have been reported to be lower in the nerve tissue of people with MS compared with healthy people.

  • Vitamin B1

    Thiamine (vitamin B1) deficiency may contribute to nerve damage. Researchers have found that injections of thiamine or thiamine combined with niacin may reduce symptoms.

    Dose:

    Refer to label instructions
    Vitamin B1
    ×
     

    Deficiency of thiamine (vitamin B1) may contribute to nerve damage.26 Many years ago, researchers found that injecting thiamine27 into the spinal cord or using intravenous thiamine combined with niacin28 in people with MS led to a reduction in symptoms. Using injectable vitamins requires medical supervision. No research has yet studied the effects of oral supplementation with B vitamins in people with MS.

  • Vitamin B3 (Niacin)

    Thiamine (vitamin B1) deficiency may contribute to nerve damage. Researchers have found that injections of thiamine or thiamine combined with niacin (vitamin B3) may reduce symptoms.

    Dose:

    Refer to label instructions
    Vitamin B3 (Niacin)
    ×
    Deficiency of thiamine may contribute to nerve damage.29 Many years ago, researchers found that injecting thiamine30 into the spinal cord or using intravenous thiamine combined with niacin31 in people with MS led to a reduction in symptoms. Using injectable vitamins requires medical supervision. No research has yet studied the effects of oral supplementation with B vitamins in people with MS.
  • Vitamin D

    Studies suggest that vitamin D may help reduce the number of MS attacks and may protect against the development of the disease.

    Dose:

    Refer to label instructions
    Vitamin D
    ×
    Animal studies have demonstrated that vitamin D can prevent an experimental form of multiple sclerosis. In humans, striking geographical differences in the prevalence of multiple sclerosis suggest that sun exposure (which promotes the synthesis of vitamin D) may protect against the development of the disease. In addition, higher blood levels of vitamin D are associated with a lower risk of developing MS.32 However, no clinical trials have been done to determine whether increasing vitamin D intake or sunlight exposure would prevent MS.

    In a preliminary trial, treatment with very large amounts of vitamin D (more than 10,000 IU per day) was associated with a decrease in the number of relapses in patients with MS; however, the decrease was not statistically significant.33 In a double-blind study of patients with MS, a large amount of vitamin D (approximately 10,000 IU per day), when compared with a moderate amount (1,000 IU per day), resulted in a significant increase in the relapse rate and in the degree of disability.34 Based on the available evidence, large amounts of vitamin D cannot be recommended as a treatment for MS. Additional research is needed to determine whether moderate amounts of vitamin D would be beneficial.

What Are Star Ratings
×
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.

References

1. Landtblom AM, Flodine U, Karlsson M, et al. Multiple sclerosis and exposure to solvents, ionizing radiation and animals. Scand J Work Environ Health 1993;19:399-404.

2. Haahr S, Koch-Henriksen N, Moller-Larsen A, et al. Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study. Mult Scler 1995;1:73-7.

3. Sedel F, Papeix C, Bellanger A, et al. High doses of biotin in chronic progressive multiple sclerosis: A pilot study. Mult Scler Relat Disord 2015;4:159–69.

4. Tourbah A, Lebrun-Frenay C, Edan G, et al. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study. Mult Scler 2016 Sep 1 [Epub ahead of print].

5. Cendrowski W. Multiple sclerosis and MaxEPA. Br J Clin Pract 1986;40:365-7.

6. Weinstock-Guttman B, Baier M, Park Y, et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids 2005;73:397-404.

7. Torkildsen O, Wergeland S, Bakke S, et al. Omega-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch Neurol 2012;69:1044-51.

8. Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypothesis 1986;21:193-200.

9. DeLuca HF, Zierold C. Mechanisms and functions of vitamin D. Nutr Rev 1998;56(2 Pt 2):S4-10 [review].

10. Yasui M, Yase Y, Ando K, et al. Magnesium concentration in brains from multiple sclerosis patients. Acta Neurol Scand 1990;81:197-200.

11. Yasui M, Ota K. Experimental and clinical studies on dysregulation of magnesium metabolism and the aetiopathogenesis of multiple sclerosis. Magnes Res 1992;5:295-302.

12. Korwin-Piotrowska T, Nocoñ D, Stankowska-Chomicz A, et al. Experience of Padma 28 in multiple sclerosis. Phytother Res 1992;6:133-6.

13. Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypothesis 1986;21:193-200.

14. DeLuca HF, Zierold C. Mechanisms and functions of vitamin D. Nutr Rev 1998;56(2 Pt 2):S4-10 [review].

15. Yasui M, Yase Y, Ando K, et al. Magnesium concentration in brains from multiple sclerosis patients. Acta Neurol Scand 1990;81:197-200.

16. Yasui M, Ota K. Experimental and clinical studies on dysregulation of magnesium metabolism and the aetiopathogenesis of multiple sclerosis. Magnes Res 1992;5:295-302.

17. Rosnowska M, Cendrowski W, Piesio B, Wieczorkiewicz M.Effect of short-term administration of sunflower oil on the blood serum level of linoleic and arachidonic acids and lipids in multiple sclerosis, Neurol Neurochir Pol, 1980;14:27-37 [in Polish].

18. Werbach M. Nutritional Influences on Illness. Tarzana, CA: Third Line Press, 1996, 434 [review].

19. Dworkin RH, Bates D, Millar JH, Paty DW. Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials. Neurology 1984;34:1441-5 [review].

20. Brochet B, Orgogozo JM, Guinot P, et al. Pilot study of Ginkgolide B, a PAF-acether specific inhibitor in the treatment of acute outbreaks of multiple sclerosis. Rev Neurol (Paris) 1992;148:299-301 [in French].

21. Koprowski H, Spitsin SV, Hooper DC. Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann Neurol 2001;49:139.

22. Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypothesis 1986;21:193-200.

23. DeLuca HF, Zierold C. Mechanisms and functions of vitamin D. Nutr Rev 1998;56(2 Pt 2):S4-10 [review].

24. Yasui M, Yase Y, Ando K, et al. Magnesium concentration in brains from multiple sclerosis patients. Acta Neurol Scand 1990;81:197-200.

25. Yasui M, Ota K. Experimental and clinical studies on dysregulation of magnesium metabolism and the aetiopathogenesis of multiple sclerosis. Magnes Res 1992;5:295-302.

26. Dines KC, Powell HC. Mast cell interactions with the nervous system: relationship to mechanisms of disease. J Neuropathol Exp Neurol 1997;56:627-40.

27. Stern EI. The intraspinal injection of vitamin B1 for the relief of intractable pain, and for inflammatory and degenerative diseases of the central nervous system. Am J Surg 1938;34:495.

28. Moore MT. Treatment of multiple sclerosis with nicotinic acid and vitamin B1. Arch Int Med 1940;65:18.

29. Dines KC, Powell HC. Mast cell interactions with the nervous system: relationship to mechanisms of disease. J Neuropathol Exp Neurol 1997;56:627-40.

30. Stern EI. The intraspinal injection of vitamin B1 for the relief of intractable pain, and for inflammatory and degenerative diseases of the central nervous system. Am J Surg 1938;34:495.

31. Moore MT. Treatment of multiple sclerosis with nicotinic acid and vitamin B1. Arch Int Med 1940;65:18.

32. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-8.

33. Burton JM, Kimball S, Vieth R, et al. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 2010;74:1852-9.

34. Stein MS, Liu Y, Gray OM, et al. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology 2011;77:1611-8.

35. Swank RL. Multiple sclerosis: fat-oil relationship. Nutrition 1991;7:368-76.

36. Esparza ML, Saski S, Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. Am J Epidemiol 1995;142:733-7.

37. Ghadirian P, Jain M, Ducic S, et al. Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol 1998;27:845-52.

38. Malosse D, Perron H, Sasco A, Seigneurin JM. Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study. Neuroepidemiology 1992;11:304-12.

39. Tola MR, Granieri E, Malagu S, et al. Dietary habits and multiple sclerosis. A retrospective study in Ferrara, Italy. Acta Neurol (Napoli) 1994;16:189-97.

40. Esparza ML, Saski S, Kesteloot H. Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. Am J Epidemiol 1995;142:733-7.

41. Ghadirian P, Jain M, Ducic S, et al. Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol 1998;27:845-52.

42. Hadjivassiliou M, Gibson A, Davies-Jones GA, et al. Does cryptic gluten sensitivity play a part in neurological illness? Lancet 1996;347:369-71.

43. Mortensen JT, Bronnum-Hansen H, Rasmussen K. Multiple sclerosis and organic solvents. Epidemiology 1998;9:168-71.

44. Juntunen J, Kinnunen E, Antti-Poika M, Koskenvuo M. Multiple sclerosis and occupational exposure to chemicals: a co-twin control study of a nationwide series of twins. Br J Ind Med 1989;46:417-9.

45. Landtblom AM, Flodin U, Soderfeldt B, et al. Organic solvents and multiple sclerosis: a synthesis of the current evidence. Epidemiology 1996;7:429-33 [review].

46. Blisard KS, Kornfeld M, McFeeley PJ, Smialek JE. The investigation of alleged insecticide toxicity: a case involving chlordane exposure, multiple sclerosis, and peripheral neuropathy. J Forensic Sci 1986;31:1499-504.

47. Landtblom AM, Flodine U, Karlsson M, et al. Multiple sclerosis and exposure to solvents, ionizing radiation and animals. Scand J Work Environ Health 1993;19:399-404.

48. Krebs JM, Park RM, Boal WL. A neurological disease cluster at a manufacturing plant. Arch Environ Health 1995;50:190-5.

49. Emre M, de Decker C. Effects of cigarette smoking on motor functions in patients with multiple sclerosis. Arch Neurol 1992;49:1243-7.

50. Fung YK, Meade AG, Rack EP, Blotcky AJ. Brain mercury in neurodegenerative disorders. J Toxicol Clin Toxicol 1997;35:49-54.

51. Siblerud RL, Kienholz E. Evidence that mercury from silver dental fillings may be an etiological factor in multiple sclerosis. Sci Total Environ 1994;142:191-205.

52. Bangsi D, Ghadirian P, Ducic S, et al. Dental amalgam and multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol 1998;27:667-71.

53. Craelius W. Comparative epidemiology of multiple sclerosis and dental caries. J Epidemiol Community Health 1978;32:155-65.

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. Self-treatment is not recommended for life-threatening conditions that require medical treatment under a doctor's care. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.

Log In

You need to log into the site to use this feature

Create A Free Account To Use Medicine Chest

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use Medicine Chest

Create A Free Account To Use this feature

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use this feature

You will be redirected to your program in 5 seconds.

Hi there.

Our Terms and Conditions and Privacy Policy have recently been updated.

Learn More


I Accept

By declining you will be logged out of your account

;